N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide

C36H38N12O6 — CID 69242503

IUPACN-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide
SMILESCCn1nnc(C2OC(n3cnc4c(NCC(c5ccc(O)cc5)c5ccc(O)cc5)nc(N5CC[C@@H](NC(=O)c6ccncc6)C5)nc43)C(O)C2O)n1
InChIInChI=1S/C36H38N12O6/c1-2-48-44-32(43-45-48)30-28(51)29(52)35(54-30)47-19-39-27-31(38-17-26(20-3-7-24(49)8-4-20)21-5-9-25(50)10-6-21)41-36(42-33(27)47)46-16-13-23(18-46)40-34(53)22-11-14-37-15-12-22/h3-12,14-15,19,23,26,28-30,35,49-52H,2,13,16-18H2,1H3,(H,40,53)(H,38,41,42)/t23-,28?,29?,30?,35?/m1/s1
InChIKeyVBKQVTPUMSUGAB-QLCDXHTASA-N
MW734.78 g/mol
LogP1.88
Rot. Bonds11

About N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide

N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide (PubChem CID 69242503) has the molecular formula C36H38N12O6 and a molecular weight of 734.78 g/mol. Its IUPAC name is N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide.

Molecular Properties

Compound NameN-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide
PubChem CID69242503
Molecular FormulaC36H38N12O6
Molecular Weight734.78 g/mol
Exact Mass734.30
IUPAC NameN-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide
SMILESCCn1nnc(C2OC(n3cnc4c(NCC(c5ccc(O)cc5)c5ccc(O)cc5)nc(N5CC[C@@H](NC(=O)c6ccncc6)C5)nc43)C(O)C2O)n1
InChIInChI=1S/C36H38N12O6/c1-2-48-44-32(43-45-48)30-28(51)29(52)35(54-30)47-19-39-27-31(38-17-26(20-3-7-24(49)8-4-20)21-5-9-25(50)10-6-21)41-36(42-33(27)47)46-16-13-23(18-46)40-34(53)22-11-14-37-15-12-22/h3-12,14-15,19,23,26,28-30,35,49-52H,2,13,16-18H2,1H3,(H,40,53)(H,38,41,42)/t23-,28?,29?,30?,35?/m1/s1
InChIKeyVBKQVTPUMSUGAB-QLCDXHTASA-N
XLogP1.88
TPSA234.61 Ų
H-Bond Donors6
H-Bond Acceptors17
Rotatable Bonds11
Heavy Atoms54
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500734.78
LogP ≤ 51.88
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1017

Analyze N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide?
The IUPAC name of N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide (CID 69242503) is N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide.
What is the SMILES notation for N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide?
The canonical SMILES for N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide is CCn1nnc(C2OC(n3cnc4c(NCC(c5ccc(O)cc5)c5ccc(O)cc5)nc(N5CC[C@@H](NC(=O)c6ccncc6)C5)nc43)C(O)C2O)n1.
What is the InChIKey of N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide?
The InChIKey is VBKQVTPUMSUGAB-QLCDXHTASA-N. The full InChI is InChI=1S/C36H38N12O6/c1-2-48-44-32(43-45-48)30-28(51)29(52)35(54-30)47-19-39-27-31(38-17-26(20-3-7-24(49)8-4-20)21-5-9-25(50)10-6-21)41-36(42-33(27)47)46-16-13-23(18-46)40-34(53)22-11-14-37-15-12-22/h3-12,14-15,19,23,26,28-30,35,49-52H,2,13,16-18H2,1H3,(H,40,53)(H,38,41,42)/t23-,28?,29?,30?,35?/m1/s1.
What are the key properties of N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide?
N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide has a molecular weight of 734.78 g/mol, XLogP of 1.88, 11 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R)-1-[6-[2,2-bis(4-hydroxyphenyl)ethylamino]-9-[5-(2-ethyltetrazol-5-yl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]pyrrolidin-3-yl]pyridine-4-carboxamide is sourced from PubChem (CID 69242503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).